Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol) ...

BOSTON — Samsung Biologics announced plans Wednesday to further broaden its customer base, aiming to serve the world’s top 40 pharmaceutical companies up from t ...

Alvotech and Advanz Pharma have inked a deal to expand their commercial partnership to cover three additional biosimilar candidates.

BridgeBio Pharma, Inc.'s stock soars on Attruby's launch and licensing deals. Click for more on BBIO growth, competition, and late-stage pipeline catalysts.

Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in Generation Park.

(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) and Inozyme Pharma, Inc. (INZY) Friday said that BioMarin has agreed to acquire Inozyme for about $270 million or $4 per share, in cash.

Digitization “future proofs” drug manufacturing according to the U.K. Centre for Process Innovation (CPI), which says a new blueprint will help biopharmaceutical firms navigate a digital ...

BridgeBio Pharma shares have risen 33% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $36.42, a rise of 43% in the last 12 months.

Trump could use the findings of the probe to impose certain trade restrictions on pharma products, including tariffs.

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug Stelara in the United States, the second in a wave of near-copies of the ...

In the last three months, 8 analysts have published ratings on Biomarin Pharmaceutical BMRN, offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a ...

Signal transducer and activator of transcription 6 (STAT6) is a member of the STAT family involved in the regulation of immune response and inflammation. The development of SH2 domain inhibitors ...